Related references
Note: Only part of the references are listed.A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: An update
Emmet B. Keeffe et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
TT Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Virologic response and resistance to adefovir in patients with chronic hepatitis B
SK Fung et al.
JOURNAL OF HEPATOLOGY (2006)
Long-term results of lamivudine monotherapy in Korean patients with HBeAg-positive chronic hepatitis B: Response and relapse rates, and factors related to durability of HBeAg seroconversion
SK Yoon et al.
INTERVIROLOGY (2005)
Four years of lamivudine treatment in Chinese patients with chronic hepatitis B
TT Chang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)
Determinants for sustained HBeAg response to lamivudine therapy
RN Chien et al.
HEPATOLOGY (2003)
Long-term additional lamivudine therapy enhances durability of lamivudine-induced HBeAg loss: a prospective study
SH Ryu et al.
JOURNAL OF HEPATOLOGY (2003)
Durability of serologic response after lamivudine treatment of chronic hepatitis B
JL Dienstag et al.
HEPATOLOGY (2003)
Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B:: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase
AB van Nunen et al.
GUT (2003)
Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
P Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Quantitative polymerase chain reaction assay for serum hepatitis B virus DNA as a predictive factor for post-treatment relapse after lamivudine induced hepatitis B e antigen loss or seroconversion
HC Lee et al.
GUT (2003)
Long-term safety of lamivudine treatment in patients with chronic hepatitis B
ASF Lok et al.
GASTROENTEROLOGY (2003)
Effect of virological response on post-treatment durability of lamivudine-induced HBeAg seroconversion
KM Lee et al.
JOURNAL OF VIRAL HEPATITIS (2002)
Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications
MF Yuen et al.
HEPATOLOGY (2001)
Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy
NWY Leung et al.
HEPATOLOGY (2001)
Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region
LJ Stuyver et al.
HEPATOLOGY (2001)
Hepatitis B genotypes and the response to interferon therapy
JH Kao et al.
JOURNAL OF HEPATOLOGY (2000)
Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea
BC Song et al.
HEPATOLOGY (2000)
Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B
YF Liaw et al.
GASTROENTEROLOGY (2000)
Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial
SW Schalm et al.
GUT (2000)
Share Paper
